The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
The study was designed to assess the efficacy and safety of ONGLYZA 5 mg per day compared to glipizide 5 mg, titrated as required to 20 mg as added to a stable dose of metformin (greater than or equal ...
ORLANDO, FL, June 26 /CNW/ - Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a 52-week Phase 3b study in adults with type 2 diabetes who had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results